RE:RE:RE:Ok, let's ask ourselves a question?Lets look at it another way.
say there are a few companies (candidates) that have a vaccine readily available to deploy to the poor countries around the world.
Population to be inncoulated - around 3 Billion for arguments sake.
Let's pick a number for cost of vaccine - or another approach maybe - say $1 flows to a companies top line before expenses - royalty, or if companies manufacture on thier own - whatever.
Let's say there are 4 companies then...another argument statement but let's get some dialouge.
so 3Billion x $1 is $3Billion. 2 doses perhaps ($6billion) divided by 4 compaines so 25% marketshare each...(argumentative point of course)
$2 Billion
What if like the flu there is a need to innoculate annually?
Hmmmm
Let the dialogue begin
GLTA